Joseph F. Woody
Joseph F. Woody is our chief executive officer and a member of our board of directors. He brings 20 years of healthcare leadership experience, proven success driving revenue growth and expertise in spearheading portfolio transformations to our business.
Prior to joining Halyard, Joe served as chief executive officer and president of Acelity, where, since 2011, he was responsible for overseeing the development and commercialization of their $2 billion innovative wound care and regenerative solutions business. From 2009 to 2011, Joe served as global president, vascular therapies, for Covidien, creating their new vascular division and leading the company’s $2.6 billion acquisition and integration of ev3.
Prior to his time at Covidien, Joe served as Smith & Nephew’s global president, advanced wound management, and Alliance Imaging’s vice president, Pacific operations. Joe previously served as board director for Acelity, the Advanced Medical Technology Association (AdvaMed) and Systagenix Wound Management. He also served as Chair of AdvaMed’s Wound Healing and Tissue Regeneration Sector.